These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 24783249

  • 21. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort.
    Thiébaut R, Kotti S, Jung C, Merlin F, Colombel JF, Lemann M, Almer S, Tysk C, O'Morain M, Gassull M, Binder V, Finkel Y, Pascoe L, Hugot JP.
    Am J Gastroenterol; 2009 Feb; 104(2):384-91. PubMed ID: 19174806
    [Abstract] [Full Text] [Related]

  • 22. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
    Lawrance IC, Murray K, Hall A, Sung JJ, Leong R.
    Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P.
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [Abstract] [Full Text] [Related]

  • 24. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA, Cvancarova M, Høivik ML, Moum B, Vatn MH.
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [Abstract] [Full Text] [Related]

  • 25. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
    Cruyssen BV, Peeters H, Hoffman IE, Laukens D, Coucke P, Marichal D, Cuvelier C, Remaut E, Veys EM, Mielants H, De Vos M, De Keyser F.
    Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862
    [Abstract] [Full Text] [Related]

  • 26. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
    Malícková K, Janatková I, Fucíková T, Adamec S, Lukás M.
    Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421
    [Abstract] [Full Text] [Related]

  • 27. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A, Gasiorowska A, Małecka-Panas E.
    Pol Merkur Lekarski; 2004 Aug; 17 Suppl 1():22-6. PubMed ID: 15603341
    [Abstract] [Full Text] [Related]

  • 28. Associations between TNFSF15 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: A meta-analysis.
    Zhang J, Zhang J, Wu D, Wang J, Dong W.
    Autoimmunity; 2014 Dec; 47(8):512-8. PubMed ID: 25028192
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.
    Yao F, Fan Y, Lv B, Ji C, Xu L.
    Medicine (Baltimore); 2018 Aug; 97(32):e11772. PubMed ID: 30095633
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A, Aarabi M, Aarabi M, Hedayati M, Jarollahi A, Firouzi F, Aghazadeh R, Zali MR, Hashemi M.
    Acta Gastroenterol Belg; 2009 Aug; 72(3):301-5. PubMed ID: 19902862
    [Abstract] [Full Text] [Related]

  • 31. Serological markers predict inflammatory bowel disease years before the diagnosis.
    van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, Teucher B, Kaaks R, Bergmann MM, Boeing H, Carbonnel F, Jantchou P, Boutron-Ruault MC, Tjønneland A, Olsen A, Crowe FL, Peeters PH, van Oijen MG, Bueno-de-Mesquita HB.
    Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Diagnostic value of different serological markers and correlation analysis with disease phenotype in inflammatory bowel disease].
    Tang H, Tan B, Shen BB, Zhang SL, Qian JM.
    Zhonghua Yi Xue Za Zhi; 2022 Dec 20; 102(47):3743-3748. PubMed ID: 36517423
    [Abstract] [Full Text] [Related]

  • 34. Isolated active ileitis: is it a mild subtype of Crohn's disease?
    O'Donnell S, Crotty PL, O'Sullivan M, Breslin N, O'Connor HJ, O'Morain CA, Ryan BM.
    Inflamm Bowel Dis; 2013 Aug 20; 19(9):1815-22. PubMed ID: 23751397
    [Abstract] [Full Text] [Related]

  • 35. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM, Berg AS, Harris L, Brinton D, Deiling S, Koltun WA.
    Dis Colon Rectum; 2015 Mar 20; 58(3):321-7. PubMed ID: 25664710
    [Abstract] [Full Text] [Related]

  • 36. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Szalmas PA, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M.
    World J Gastroenterol; 2015 Jun 14; 21(22):6952-64. PubMed ID: 26078573
    [Abstract] [Full Text] [Related]

  • 37. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients.
    Riis L, Vind I, Vermeire S, Wolters F, Katsanos K, Politi P, Freitas J, Mouzas IA, O'Morain C, Ruiz-Ochoa V, Odes S, Binder V, Munkholm P, Moum B, Stockbrügger R, Langholz E, European Collaborative Study Group on Inflammatory Bowel Disease.
    Inflamm Bowel Dis; 2007 Jan 14; 13(1):24-32. PubMed ID: 17206636
    [Abstract] [Full Text] [Related]

  • 38. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
    Zhang S, Luo J, Li J, Wu Z, Hu C, Li P, Deng C, Zhang F, Qian J, Li Y.
    Clin Chem Lab Med; 2017 May 01; 55(6):865-875. PubMed ID: 27831916
    [Abstract] [Full Text] [Related]

  • 39. Serum antibodies associated with complex inflammatory bowel disease.
    Elkadri AA, Stempak JM, Walters TD, Lal S, Griffiths AM, Steinhart AH, Silverberg MS.
    Inflamm Bowel Dis; 2013 Jun 01; 19(7):1499-505. PubMed ID: 23702714
    [Abstract] [Full Text] [Related]

  • 40. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.
    Halme L, Turunen U, Heliö T, Paavola P, Walle T, Miettinen A, Järvinen H, Kontula K, Färkkilä M.
    Scand J Gastroenterol; 2002 Jun 01; 37(6):692-8. PubMed ID: 12126248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.